← Leaderboards
Ching-Shih Chen
University Of Kentucky
$8,095,534
Attributed
$8,095,534
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $744.6K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$8,095,534 · 10
By mechanism
R01$5,786,503 · 4
R21$1,654,416 · 5
P50$654,615 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Russell J Mumper$6,017,636
- Jin-Ming Yang$5,088,324
- Markos Leggas$4,898,273
- William H St Clair$3,066,919
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorSignal TransductionLeadPharmaceutical PreparationsDefectMolecularLaboratoriesIn VivoBaseSmall MoleculePrevention StrategyToxic EffectCancer CellChemopreventive AgentCellsTumor GrowthDesignCancer EtiologyMolecular TargetClinical ManagementCessation Of LifeOralExhibitsResources
Grant awards (38)
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents$319,550
R01 · FY2016 · CA · contact PI
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents$319,550
R01 · FY2015 · CA · contact PI
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention$285,581
R01 · FY2015 · CA · contact PI
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents$319,291
R01 · FY2014 · CA · contact PI
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention$277,014
R01 · FY2014 · CA · contact PI
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention$268,446
R01 · FY2013 · CA · contact PI
Medicinal Chemistry$124,278
P50 · FY2013 · CA · contact PI
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention$285,581
R01 · FY2012 · CA · contact PI
Novel AMPK Activators in Breast Cancer Prevention$199,013
R21 · FY2012 · CA · contact PI
Medicinal Chemistry$133,482
P50 · FY2012 · CA · contact PI
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention$285,581
R01 · FY2011 · CA · contact PI
Novel AMPK Activators in Breast Cancer Prevention$165,844
R21 · FY2011 · CA · contact PI
Medicinal Chemistry$127,416
P50 · FY2011 · CA · contact PI
Targeting proapoptotic PKCdelta signaling in hepatocellular carcinoma$198,000
R21 · FY2010 · CA · contact PI
Indole-3-carbinol derivatives with enhanced chemopreventive activities$198,000
R21 · FY2010 · CA · contact PI
Medicinal Chemistry$134,805
P50 · FY2010 · CA · contact PI
Targeting Akt and Bcl-2 in Prostate Cancer Prevention$279,963
R01 · FY2009 · CA · contact PI
Indole-3-carbinol derivatives with enhanced chemopreventive activities$165,000
R21 · FY2009 · CA · contact PI
Targeting proapoptotic PKCdelta signaling in hepatocellular carcinoma$165,000
R21 · FY2009 · CA · contact PI
Medicinal Chemistry$134,634
P50 · FY2009 · CA · contact PI
Targeting Akt and Bcl-2 in Prostate Cancer Prevention$279,963
R01 · FY2008 · CA · contact PI
Targeting Akt and Bcl-2 in Prostate Cancer Prevention$279,963
R01 · FY2007 · CA · contact PI
Targeting Akt and Bcl-2 in Prostate Cancer Prevention$288,324
R01 · FY2006 · CA · contact PI
Targeting Akt and Bcl-2 in Prostate Cancer Prevention$295,263
R01 · FY2005 · CA
Apoptosis Regulation by Lipid Signals in Prostate Cancer$199,125
R01 · FY2005 · CA
Novel Celecoxib Derivatives as Chemopreventive Agents$134,550
R21 · FY2005 · CA
Novel Function of PI 3-Kinase in Calcium Regulation$221,250
R01 · FY2004 · GM
Apoptosis Regulation by Lipid Signals in Prostate Cancer$199,125
R01 · FY2004 · CA
Novel Celecoxib Derivatives as Chemopreventive Agents$134,550
R21 · FY2004 · CA
Novel Function of PI 3-Kinase in Calcium Regulation$221,250
R01 · FY2003 · GM
Apoptosis Regulation by Lipid Signals in Prostate Cancer$199,125
R01 · FY2003 · CA
Novel Function of PI 3-Kinase in Calcium Regulation$221,063
R01 · FY2002 · GM
Apoptosis Regulation by Lipid Signals in Prostate Cancer$199,125
R01 · FY2002 · CA
Testing of Novel Apoptotic Agents in Prostate Cancer$147,459
R21 · FY2002 · CA
Novel Function of PI 3-Kinase in Calcium Regulation$295,500
R01 · FY2001 · GM
Apoptosis Regulation by Lipid Signals in Prostate Cancer$198,450
R01 · FY2001 · CA
Testing of Novel Apoptotic Agents in Prostate Cancer$147,000
R21 · FY2001 · CA
INOSITOL PHOSPHATES--MOLECULAR AND FUNCTIONAL DIVERSITY$48,420
R01 · FY2000 · GM